
Conference Coverage
Latest Content

Commentaries Highlight Promise, Questions for Nalbuphine in IPF Cough

EHA 2026: Hematology Comes to Stockholm With Patients at the Forefront

Alopecia in Gender-Diverse Patients: Beyond Cosmetics to Clinical Significance

CLL Immune Dysfunction Drives Infections, Cytopenias, and Cancer Risk

Health Equity & Access Weekly Roundup: June 5, 2026

Shorts










Podcasts
Center on Health Equity & Access
All News

FDA decisions in May 2026 included 5 major oncology approvals, including first-in-class therapies for breast cancer, AML, MCL, and NMIBC.

Late-breaker data from EASL Congress 2026 mark a pivotal moment in chronic hepatitis B research.

Canopy remote therapeutic monitoring with ePROs cuts hospitalizations and extends time to discontinuation in metastatic cancer, saving millions.

Middle socioeconomic status (SES) elevates multimorbidity risk; healthy lifestyles mitigate this. Targeted interventions for middle-SES populations, especially middle-aged non-Hispanic White women, are crucial.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Men and urban minority patients with early-onset CRC face elevated CVD death risk, highlighting gaps in survivorship care and research, Meng-Han Tsai, PhD, said.

Three-year trial data show baricitinib sustains and deepens hair, eyebrow, and eyelash regrowth in severe alopecia areata, with stable long-term safety.

Chronic inflammation, hormonal imbalance, and surgical management all deplete ovarian reserve in endometriosis patients, a new systematic review finds.

Structural racism was associated with wider NSCLC survival disparities, with a 10-point Black-White gap in highly segregated counties.

Veterans with Alzheimer disease (AD), identified using clinical notes, have higher health care utilization than veterans without AD.
























